BCL2 and adenoma: This revealed a significant decrease in BCL-2 expression in adenomas compared to healthy tissue and a further decrease in CRC tumors, which was also confirmed in the TCGA COREAD cohort (Fig. 5a and Supplementary Fig. 5a).